Presents opioid and fentanyl use trends and describes whether expected substance use aligned with actual substance contents.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Examines the prevalence of non-medical prescription stimulants use by college and university students.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Provides key context, data, and recommendations on improving the substance use health of employees for employers and other partners (e.g., unions, associations, health professionals) from industries with safety-sensitive positions, based on input…
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Summarizes four important facts currently known about COVID-19 and how it can affect people who smoke or vape cannabis products.
Your experience and insight are important in creating quality workplace policies.
Examines best practices and services that should be available to people experiencing, or at risk of experiencing, harms from opioid use. The report was developed for Health Canada’s Federal, Provincial and Territorial Treatment Task Group.…
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Summarizes key findings of the Closing the Gaps studies, specifically the legalization impact, medical use versus nonmedical use, mental and physical health effects, purchase decisions, modalities of use, polysubstance use and stigma.
